| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/06/2002 | CN1334819A Connective tissue growth factor fragments and methods and uses thereof |
| 02/05/2002 | US6344596 Expression of active human factor IX in mammary tissue and of milk non human transgenic mammals |
| 02/05/2002 | US6344576 Phospholipid-analogous compounds |
| 02/05/2002 | US6344550 A dna molecule; diagnosing, monitoring and therapy of breast cancer |
| 02/05/2002 | US6344542 A polypeptides involved in signal transduction; therapy and diagnosis of cancers, diabetes, obesity, anorexia, asthma, parkinson's disease, heart disease, strokes, allergies, schizophrenia, huntington's disease and tourett's syndrome |
| 02/05/2002 | US6344475 Cystic fibrosis |
| 02/05/2002 | US6344446 Gene delivery |
| 02/05/2002 | US6344441 Lipoprotein-regulating medicaments |
| 02/05/2002 | US6344342 An isolated polynucleotide encoding a polypeptide; diagnosis and therapy for infections caused by hiv-1 or hiv-2, cancers, diabetes, asthma, parkinson's disease, ulcers, allergies, congestive heart failure, kidney diseases, sexual disorders |
| 02/05/2002 | US6344323 Preventing cyclooxygenase-2 expression using antisense oligonucleotides that bind polynucleotides encoding cyclooxygenase; therapy for arthritis, ulcers, inflammatory bowel disease, multiple sclerosis, and alzheimer's disease |
| 02/05/2002 | US6344194 Dissolving a virus in an aqueous solution containing 6-12 g/l of a monovalent cation salt (such as nacl or kcl), or 50-100 g/l of a hexose and atomizing |
| 02/05/2002 | CA2051288C Viral targeted destruction of neoplastic cells |
| 02/04/2002 | CA2354253A1 Polypeptides or nucleic acids encoding these of a family of g-protein coupled receptors and their use for the diagnosis or treatment of disorders, for example skin disorders and their use for the identification of pharmacologically active substances |
| 02/01/2002 | WO2001007617A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 02/01/2002 | CA2380942A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 01/31/2002 | WO2002008751A2 Mild enrichment of foetal cells from peripheral blood and use thereof |
| 01/31/2002 | WO2002008448A2 Non-viral linear dna vectors and methods for using the same |
| 01/31/2002 | WO2002008436A2 Mini-adenoviral vector system for vaccination |
| 01/31/2002 | WO2002008435A1 Codon-optimized papilloma virus sequences |
| 01/31/2002 | WO2002008434A2 Bicistronic influenza comprising two genes in tandem |
| 01/31/2002 | WO2002008429A2 Vdup1 promoter and methods of use thereof |
| 01/31/2002 | WO2002008423A2 Adhesion molecules |
| 01/31/2002 | WO2002008405A1 Isocitrate dehydrogenases, their genes, and use in antioxidative system suppressive of ros-mediated diseases |
| 01/31/2002 | WO2002008389A2 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue |
| 01/31/2002 | WO2002008286A2 Zinc finger domain recognition code and uses thereof |
| 01/31/2002 | WO2002008285A2 Il-17 molecules and uses thereof |
| 01/31/2002 | WO2002008284A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/31/2002 | WO2002008271A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | WO2002008267A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/31/2002 | WO2002008263A2 Modified virus having an altered tropism |
| 01/31/2002 | WO2002008255A2 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | WO2002008242A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof |
| 01/31/2002 | WO2002007777A1 USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS |
| 01/31/2002 | WO2002007776A1 The protein kinase domain of the large subunit of herpes simplex type 2 ribonucleotide reductase (icp10pk) has anti-apoptopic activity |
| 01/31/2002 | WO2002007775A2 Fusion protein for inhibition of lipoprotein secretion |
| 01/31/2002 | WO2002007774A2 Methods for therapy of neurodegenerative disease of the brain |
| 01/31/2002 | WO2002007773A2 Multi-component biological transport systems |
| 01/31/2002 | WO2002007759A2 Clostridial toxin derivatives and methods for treating pain |
| 01/31/2002 | WO2002007757A2 Prevention and treatment of sexual arousal disorders |
| 01/31/2002 | WO2002007754A2 New use |
| 01/31/2002 | WO2001083562A3 Hybrid protein and vector encoding the same for inhibition of angiogenesis |
| 01/31/2002 | WO2001080873A3 Thrombopoietin receptor modulating peptide |
| 01/31/2002 | WO2001074381A3 Calpain inhibitors in cancer treatment |
| 01/31/2002 | WO2001072280A3 Microspheres for gene therapy |
| 01/31/2002 | WO2001071015A3 Non-squamous epithelium-specific transcription |
| 01/31/2002 | WO2001068146A3 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
| 01/31/2002 | WO2001068120A3 Uses of bombesin receptor 3 |
| 01/31/2002 | WO2001064870A3 Mutated cyclin g1 protein |
| 01/31/2002 | WO2001064185A3 Method for making, loading and sealing a cell or drug encapsulation device, and such a device |
| 01/31/2002 | WO2001062784A3 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 01/31/2002 | WO2001061017A3 Modified cytokines for use in cancer therapy |
| 01/31/2002 | WO2001057075A3 Virulence genes, proteins, and their use |
| 01/31/2002 | WO2001044482A3 Optimized t-dna transfer and vectors therefor |
| 01/31/2002 | WO2001042457A3 Uncharged antisense oligonucleotides targeted to bacterial 16s and 23s prnas and their uses |
| 01/31/2002 | WO2001036605A3 2786, a human aminopeptidase |
| 01/31/2002 | WO2001034801A3 Recombinant gelatin in vaccines |
| 01/31/2002 | WO2001031343A3 Diagnosis and therapy of cancer using sgp28-related molecules |
| 01/31/2002 | WO2001008634A3 Polynucleotide encoding a human serine protease |
| 01/31/2002 | WO2000062794A9 A non-immunosuppressive process for inducing acceptance of incompatible transplants |
| 01/31/2002 | WO1998021343A8 Genes encoding telomerase proteins |
| 01/31/2002 | US20020013288 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity |
| 01/31/2002 | US20020013286 Administering the adenoviral gene transfer vector (exogenous) encoding a gene product to a muscle and the vector is neutralized outside of the muscle by systemic neutralizing antibodies; using a chimeric coat protein for cell entry |
| 01/31/2002 | US20020013282 Transfecting a cell comprising by contacting the cell with a biologically active nucleic acid molecule in the presence of a cationic lipid which can be protonated; cationic amphiphiles to transport drugs into cells; gene therapy |
| 01/31/2002 | US20020013264 Glycosylaminoglycan (GAG) chains chemically modified with a carbodiimide such as 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide |
| 01/31/2002 | US20020013261 Contacting a localized area of tissue with the polymer; treating ischemia |
| 01/31/2002 | US20020012998 Gene transfer composition; for use in the transfection of mammalian cells |
| 01/31/2002 | US20020012997 Transducing cell; incubate cells with nucleotide sequences, insert cells into mammals, monitor mammals for phenotypic adjustment |
| 01/31/2002 | US20020012995 Negative-sense RNA virus vector for nerve cell |
| 01/31/2002 | US20020012931 High specificity marker detection |
| 01/31/2002 | US20020012914 Transfection of preferential nucleotide sequences into aggregations; mix sample and nucleotide sequences, incubate, expose to electric pulse, recover transformed aggregations |
| 01/31/2002 | US20020012903 Separating neuronal pluripotent stem cells from mixed sample of cells; transform cells, express marker, recover cells expressing marker |
| 01/31/2002 | US20020012696 In gene therapy and in in vitro and in vivo transfection |
| 01/31/2002 | US20020012661 Methods for introducing genes into mammalian subjects |
| 01/31/2002 | US20020012660 Method of preparing a somatic cells for nuclear transfer |
| 01/31/2002 | US20020012657 Method for in vitro preconditioning of myoblasts before transplantation |
| 01/31/2002 | DE10031179A1 Introducing active molecules into the nucleus of eukaryotic cells, useful for transfection and gene therapy, by applying controlled electrical pulse |
| 01/31/2002 | CA2797652A1 Multi-component biological transport systems |
| 01/31/2002 | CA2429502A1 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue |
| 01/31/2002 | CA2418333A1 Bicistronic influenza comprising two genes in tandem |
| 01/31/2002 | CA2418282A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/31/2002 | CA2418215A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | CA2418179A1 The protein kinase domain of the large subunit of herpes simplex type 2 ribonucleotide reductase (icp10pk) has anti-apoptopic activity |
| 01/31/2002 | CA2416793A1 Inhibition of lipoprotein secretion |
| 01/31/2002 | CA2416676A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof |
| 01/31/2002 | CA2416664A1 Zinc finger domain recognition code and uses thereof |
| 01/31/2002 | CA2416538A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/31/2002 | CA2416496A1 Adhesion molecules |
| 01/31/2002 | CA2416488A1 Codon-optimized papilloma virus sequences |
| 01/31/2002 | CA2416408A1 Methods for therapy of neurodegenerative disease of the brain |
| 01/31/2002 | CA2416358A1 Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type i interferons |
| 01/31/2002 | CA2415077A1 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | CA2413851A1 Modified virus having an altered tropism |
| 01/31/2002 | CA2412626A1 Il-17 molecules and uses thereof |
| 01/30/2002 | EP1176200A2 Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases or wound healing and their use in indentifying pharmacologically acitve substances |
| 01/30/2002 | EP1176198A1 Novel fetal genes |
| 01/30/2002 | EP1175910A2 Methods and compounds for prevention of graft rejection |
| 01/30/2002 | EP1175909A2 Therapeutic methods and compositions based on serrate proteins and nucleic acids |
| 01/30/2002 | EP1175616A1 Methods for the diagnosis and treatment of metastatic prostate tumors |
| 01/30/2002 | EP1175513A1 MinK-RELATED GENES, FORMATION OF POTASSIUM CHANNELS AND ASSOCIATION WITH CARDIAC ARRHYTHMIA |
| 01/30/2002 | EP1175503A1 49 human secreted proteins |